Skip to main content

Peer Review reports

From: Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice

Original Submission
26 Feb 2019 Submitted Original manuscript
27 Apr 2019 Reviewed Reviewer Report - Tamara Matysiak-Budnik
21 May 2019 Reviewed Reviewer Report - Arvind Dasari
6 Jul 2019 Author responded Author comments - Gemma Bruera
Resubmission - Version 2
6 Jul 2019 Submitted Manuscript version 2
14 Sep 2019 Reviewed Reviewer Report - Tamara Matysiak-Budnik
Resubmission - Version 3
Submitted Manuscript version 3
29 Sep 2019 Editorially accepted
16 Oct 2019 Article published 10.1186/s12885-019-6214-z

You can find further information about peer review here.

Back to article page